Arbutus Biopharma Corp
NASDAQ:ABUS
Income Statement
Earnings Waterfall
Arbutus Biopharma Corp
Revenue
|
18.1m
USD
|
Operating Expenses
|
-96.2m
USD
|
Operating Income
|
-78.1m
USD
|
Other Expenses
|
5.3m
USD
|
Net Income
|
-72.8m
USD
|
Income Statement
Arbutus Biopharma Corp
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
15
N/A
|
18
+15%
|
16
-6%
|
18
+8%
|
15
-16%
|
15
+2%
|
17
+11%
|
17
-2%
|
23
+41%
|
21
-11%
|
18
-15%
|
14
-19%
|
1
-90%
|
1
-25%
|
2
+65%
|
8
+331%
|
11
+34%
|
12
+11%
|
12
+2%
|
7
-44%
|
6
-13%
|
5
-13%
|
5
-11%
|
6
+32%
|
6
-1%
|
7
+13%
|
8
+13%
|
6
-20%
|
7
+13%
|
8
+9%
|
8
+11%
|
10
+22%
|
11
+8%
|
21
+95%
|
33
+55%
|
36
+8%
|
39
+8%
|
33
-15%
|
24
-29%
|
22
-5%
|
18
-18%
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(27)
|
(32)
|
(38)
|
(42)
|
(48)
|
(51)
|
(57)
|
(70)
|
(79)
|
(86)
|
(107)
|
(103)
|
(102)
|
(100)
|
(81)
|
(81)
|
(81)
|
(81)
|
(81)
|
(81)
|
(76)
|
(78)
|
(78)
|
(80)
|
(77)
|
(72)
|
(65)
|
(61)
|
(65)
|
(68)
|
(74)
|
(79)
|
(85)
|
(90)
|
(98)
|
(100)
|
(104)
|
(105)
|
(100)
|
(102)
|
(96)
|
|
Selling, General & Administrative |
(5)
|
(7)
|
(8)
|
(8)
|
(9)
|
(9)
|
(15)
|
(21)
|
(26)
|
(31)
|
(47)
|
(43)
|
(39)
|
(37)
|
(17)
|
(17)
|
(16)
|
(15)
|
(15)
|
(14)
|
(16)
|
(17)
|
(21)
|
(22)
|
(18)
|
(17)
|
(12)
|
(13)
|
(15)
|
(15)
|
(16)
|
(16)
|
(17)
|
(18)
|
(19)
|
(18)
|
(18)
|
(18)
|
(19)
|
(22)
|
(22)
|
|
Research & Development |
(21)
|
(25)
|
(30)
|
(33)
|
(39)
|
(41)
|
(41)
|
(49)
|
(52)
|
(54)
|
(60)
|
(59)
|
(61)
|
(62)
|
(62)
|
(62)
|
(63)
|
(63)
|
(64)
|
(65)
|
(58)
|
(59)
|
(55)
|
(56)
|
(58)
|
(53)
|
(51)
|
(45)
|
(47)
|
(50)
|
(55)
|
(60)
|
(66)
|
(71)
|
(78)
|
(82)
|
(84)
|
(84)
|
(79)
|
(79)
|
(74)
|
|
Depreciation & Amortization |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(1)
|
(0)
|
1
|
(2)
|
(2)
|
(1)
|
(1)
|
(0)
|
|
Operating Income |
(12)
N/A
|
(15)
-25%
|
(21)
-43%
|
(24)
-15%
|
(33)
-35%
|
(36)
-8%
|
(40)
-13%
|
(54)
-33%
|
(55)
-3%
|
(65)
-17%
|
(90)
-38%
|
(89)
+1%
|
(100)
-13%
|
(99)
+2%
|
(79)
+20%
|
(73)
+8%
|
(70)
+4%
|
(69)
+2%
|
(69)
+0%
|
(74)
-8%
|
(70)
+5%
|
(72)
-3%
|
(74)
-2%
|
(74)
+0%
|
(71)
+3%
|
(65)
+8%
|
(57)
+12%
|
(55)
+5%
|
(58)
-6%
|
(60)
-4%
|
(66)
-9%
|
(69)
-5%
|
(74)
-7%
|
(69)
+6%
|
(64)
+7%
|
(64)
+1%
|
(65)
-3%
|
(72)
-10%
|
(76)
-6%
|
(80)
-5%
|
(78)
+2%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(2)
|
(14)
|
(11)
|
(11)
|
(5)
|
13
|
9
|
25
|
26
|
24
|
25
|
11
|
4
|
0
|
1
|
3
|
4
|
3
|
27
|
24
|
21
|
17
|
(11)
|
(13)
|
(22)
|
(19)
|
(17)
|
(17)
|
(6)
|
(6)
|
(6)
|
(3)
|
(3)
|
(2)
|
(2)
|
(1)
|
0
|
2
|
3
|
4
|
5
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
(0)
|
(10)
|
(10)
|
(48)
|
(49)
|
(40)
|
(197)
|
(159)
|
(393)
|
(394)
|
(237)
|
(237)
|
(42)
|
(42)
|
(45)
|
(53)
|
(12)
|
(12)
|
(9)
|
(73)
|
(73)
|
(73)
|
(73)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(14)
N/A
|
(29)
-112%
|
(32)
-11%
|
(35)
-8%
|
(39)
-11%
|
(33)
+15%
|
(42)
-27%
|
(77)
-85%
|
(79)
-2%
|
(81)
-3%
|
(261)
-222%
|
(237)
+9%
|
(489)
-107%
|
(492)
-1%
|
(315)
+36%
|
(307)
+3%
|
(109)
+65%
|
(108)
+1%
|
(86)
+20%
|
(103)
-20%
|
(61)
+41%
|
(67)
-10%
|
(94)
-39%
|
(160)
-71%
|
(166)
-4%
|
(157)
+6%
|
(148)
+6%
|
(71)
+52%
|
(64)
+11%
|
(66)
-4%
|
(72)
-8%
|
(72)
-1%
|
(76)
-6%
|
(71)
+7%
|
(66)
+7%
|
(64)
+2%
|
(65)
-1%
|
(70)
-8%
|
(73)
-4%
|
(75)
-3%
|
(73)
+3%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15
|
16
|
0
|
81
|
66
|
105
|
0
|
0
|
0
|
7
|
0
|
0
|
12
|
4
|
0
|
4
|
13
|
13
|
13
|
13
|
0
|
0
|
0
|
0
|
0
|
0
|
(4)
|
(4)
|
(4)
|
(4)
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(14)
|
(29)
|
(32)
|
(35)
|
(39)
|
(33)
|
(42)
|
(62)
|
(63)
|
(65)
|
(180)
|
(171)
|
(384)
|
(387)
|
(275)
|
(267)
|
(101)
|
(100)
|
(79)
|
(92)
|
(57)
|
(63)
|
(89)
|
(147)
|
(154)
|
(144)
|
(135)
|
(71)
|
(64)
|
(66)
|
(72)
|
(72)
|
(76)
|
(76)
|
(70)
|
(69)
|
(69)
|
(70)
|
(73)
|
(75)
|
(73)
|
|
Net Income (Common) |
(14)
N/A
|
(29)
-112%
|
(32)
-11%
|
(35)
-8%
|
(39)
-11%
|
(33)
+15%
|
(42)
-27%
|
(62)
-49%
|
(63)
-1%
|
(65)
-4%
|
(180)
-177%
|
(171)
+5%
|
(384)
-125%
|
(387)
-1%
|
(275)
+29%
|
(267)
+3%
|
(85)
+68%
|
(86)
-1%
|
(68)
+22%
|
(83)
-23%
|
(67)
+19%
|
(73)
-9%
|
(100)
-36%
|
(158)
-58%
|
(165)
-4%
|
(156)
+6%
|
(147)
+6%
|
(83)
+43%
|
(76)
+9%
|
(79)
-4%
|
(84)
-7%
|
(87)
-3%
|
(88)
-2%
|
(85)
+4%
|
(76)
+10%
|
(69)
+9%
|
(69)
0%
|
(70)
-1%
|
(73)
-4%
|
(75)
-3%
|
(73)
+3%
|
|
EPS (Diluted) |
-0.76
N/A
|
-1.47
-93%
|
-1.46
+1%
|
-1.57
-8%
|
-1.8
-15%
|
-1.08
+40%
|
-0.76
+30%
|
-1.22
-61%
|
-1.38
-13%
|
-1.25
+9%
|
-3.41
-173%
|
-3.18
+7%
|
-7.24
-128%
|
-7.12
+2%
|
-5.03
+29%
|
-4.86
+3%
|
-1.55
+68%
|
-1.57
-1%
|
-1.19
+24%
|
-1.49
-25%
|
-1.21
+19%
|
-1.33
-10%
|
-1.76
-32%
|
-2.78
-58%
|
-2.89
-4%
|
-2.3
+20%
|
-2.1
+9%
|
-1.04
+50%
|
-1
+4%
|
-0.84
+16%
|
-0.86
-2%
|
-0.85
+1%
|
-0.83
+2%
|
-0.56
+33%
|
-0.51
+9%
|
-0.45
+12%
|
-0.46
-2%
|
-0.43
+7%
|
-0.43
N/A
|
-0.46
-7%
|
-0.44
+4%
|